Clinical characteristics of peripheral exudative hemorrhagic chorioretinopathy and its response to bevacizumab therapy

devices from different manufactures or batches may not prevent infection. By operating on both eyes at the same sitting it is logical that there is a potential increase in risk, particularly from sources such as airborne exposure in the operating theater. We recognize that endophthalmitis does not equate to blindness, but it is a frequently devastating and… CONTINUE READING